In connection with organizational restructuring, Evolent Health, Inc. announced the departure of Steve Tutewohl, Chief Operating Officer. Mr. Tutewohl's departure, effective July 3, 2023, will be treated as an involuntary termination without cause consistent with his existing severance and change-in-control agreement. On May 3, 2023, the Company's Board of Directors appointed Emily Rafferty to serve as the Company's Chief Operating Officer, effective July 3, 2023.

Ms. Rafferty, 40, has served as the President and Chief Operating Officer of Evolent Health Services, a former reporting segment of the Company which houses the Company's administrative simplification solution and certain supporting population health infrastructure since September 2020. Prior to becoming President and Chief Operating Officer of Evolent Health Services, Ms. Rafferty held multiple leadership roles within the Company including President, Market Operations and Pharmacy Services, as well as Senior Vice President, Advisory Services.